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ABSTRACT
The Papillomavirus Episteme (PaVE) is a database
of curated papillomavirus genomic sequences, ac-
companied by web-based sequence analysis tools.
This update describes the addition of major new fea-
tures. The papillomavirus genomes within PaVE have
been further annotated, and now includes the ma-
jor spliced mRNA transcripts. Viral genes and tran-
scripts can be visualized on both linear and cir-
cular genome browsers. Evolutionary relationships
among PaVE reference protein sequences can be
analysed using multiple sequence alignments and
phylogenetic trees. To assist in viral discovery, PaVE
offers a typing tool; a simplified algorithm to de-
termine whether a newly sequenced virus is novel.
PaVE also now contains an image library containing
gross clinical and histopathological images of pa-
pillomavirus infected lesions. Database URL: https:
//pave.niaid.nih.gov/.
INTRODUCTION
Episteme is derived from the ancient Greek noun 
(knowledge or science) and verb  (to know). This
definition symbolizes our goal to provide accurate informa-
tion about papillomaviruses (PVs) in order to understand
their genomic structure, perform comparative genomics
analyses and to assist in the understanding and treatment of
papillomavirus-associated diseases. Thus, the database was
named The Papillomavirus Episteme (or PaVE) (1).
The Papillomaviridae are a family of circular viruses with
a double-stranded DNA genome of about 7.9 kb. A typi-
cal papillomavirus genome encodes seven to eight proteins.
Most highly conserved are the E1 and E2 regulatory pro-
teins (2,3) and the L1 and L2 structural proteins (4,5). In
addition to this core set of proteins, most viruses encode
for E6 and E7 proteins, which optimize the cellular milieu
for the viral life cycle (6,7). Certain viruses also express
small, hydrophobic proteins that are designated E5 (8) or
E10 (9). The highly divergent, yet highly expressed, E4 pro-
tein is imprinted within the E2 open reading frame (ORF)
(10). The Upstream Regulatory Region (URR), otherwise
known as the Long Control Region (LCR), is located be-
tween the L1 and E6 ORFs, and contains cis- responsive
elements involved in transcription and replication (11,12).
Taxonomic classification of papillomaviruses is based on
nucleotide similarity across the L1 ORF (13). The family
Papillomaviridae contains 49 genera, each of which is fur-
ther divided into several species. To be designated as a new
type, an individual PV type cannot share >90% similarity
to any other known PV type (14,15). Individual types have
been shown to be highly species and tissue specific. To date,
papillomaviruses have been described in fish (16), reptiles
(17,18), birds (19) and mammals (20). Based on the sugges-
tion that papillomaviruses have coevolved with their hosts
(21), it appears that papillomaviruses have been an evolu-
tionary success for over 500 million years.
Since its inception, PaVE has become highly respected
within the papillomavirus community. An important aim of
the PaVE database is to provide clinicians, epidemiologists
and bench scientists with a uniform data source, thereby fa-
cilitating cross pollination among these different, yet com-
plementary research areas (1). Here, we describe major ad-
ditions and updates to the PaVE database, new analysis
tools, and an enhanced web-based user interface.
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IMPROVEMENTS
Software details
The PaVE utilizes open platform web technologies, and is
deployed on a server runningApacheTomcat and aMySQL
database. The underlying code is written in Java, and uses
Hibernate database queries with BioJava. The web graphi-
cal user interface is developed using theGoogleWebToolkit
and jQuery. Details including versions of these platforms
and visualization and analysis tools are described in Sup-
plementary Table S1.
Enhanced interface design
Since its initial deployment, numerous new tools and re-
sources have been added to PaVE. To accommodate these
additions, and simplify navigation, the web page inter-
face was redesigned (Figure 1). Users can navigate the
database via ‘Search’, ‘Analyse’ or ‘Explore’ pages. Integra-
tion of advanced analysis tools (multiple sequence align-
ment, BLAST, phylogenetic tools) with visualization tools
(sequence tree, protein structure and image viewers) in the
Search feature, enables users to perform highly targeted
searches and analysis for DNA and protein sequences. The
‘Analyse’ page gives direct access to the Multiple Sequence
Alignment, Protein Structure Viewer and L1 Taxonomy
tools. ‘Explore’ lists extensive information related to the
functional genomics of papillomaviruses, as shown in Fig-
ure 1.
Database content
The initial description of the PaVE database included 241
completely annotated viral genomes. The PaVE database
is updated four times per year. An automated GenBank
search identifies putative novel papillomavirus types not
currently present in PaVE. The current PaVE database con-
tains 347 annotated papillomavirus genomes, 3562 genes
and regions, 3215 protein sequences and 57 protein struc-
tures, which users can explore, analyse or download. To be
recognized as a novel papillomavirus type, a viral genome
has to fulfill a strict set of requirements (for details see
(14,15)): (i) The entire viral genome must be cloned; (ii) the
L1 sequence cannot share >90% nucleotide sequence iden-
tity with its closest neighbour and (iii) the cloned genome
must be submitted to, and reviewed by, the International
Human Papillomavirus Reference Centre (22). However,
because of recent advances in Next-Generation sequencing,
several novel genomes have been described (for a review see
(13)) that do not meet all these requirements, and will there-
fore not be recognized as novel viral types by the Interna-
tional Human Papillomavirus Reference Centre. In order
to reflect the true diversity of papillomaviruses, PaVE in-
cludes viruses that meet the ‘90% sequence identity’ rule,
even when the additional requirements are not met. At the
time of publication, 20 of the 347 viral genomes in PaVE are
considered to be non-reference genomes. Throughout the
PaVE database, the official named viral types are indicated
with the suffix ‘REF’. Non-reference viruses are identified
by the appendix ‘nr’ (e.g. HPV-mXXXXnr; where XXXX
reflects the original name given by the submitting authors).
All PaVE tools contain a filter to enable inclusion or exclu-
sion of these ‘non-reference’ viruses. When a non-reference
genome becomes recognized by the reference centre (i.e.
meets all inclusion criteria), the non-reference genome will
be transferred to the reference genome category in PaVE.
Manual editing of viral genomes
For most viral types, the automated annotation process has
proven to be highly accurate. The resulting annotations are
manually verified to ensure that they include all expected
ORFs, based on papillomavirus biology and phylogenetic
classification of the virus. Finally, amultiple sequence align-
ment of all homologous viral ORFs is used to verify that
the proteins are of similar length, and that no frame-shifts
or deletions are present within the ORF. In certain cases, vi-
ral genome sequences are manually edited to restore a viral
ORF (see (1) for details). Genomes that have been to date
are shown in Supplementary Table S2. Edited genomes are
noted in the PaVE database and links to the original Gen-
Bank record are provided.
Expanded annotation of viral genomes
As was described in the initial description of the PaVE
database (1), viral ORFs are identified by a BLASTp
search against a customdatabase. In addition, current scien-
tific knowledge is applied into the annotation process and
genomes are manually curated, if necessary. For example,
the L1 protein is usually translated from a spliced mRNA,
with a highly conserved splice acceptor motif just upstream
of the L1 ORF [YYNYAG(A)TG; Y represents T or C]. In
addition toORFs and associated proteins, PaVE also anno-
tates conserved spliced transcripts (see next paragraph for
more details).
Splice site prediction is performed using the validated
ASSP tool (23). The potential list of splice donor/acceptor
pairs are filtered based on certain assumptions. These as-
sumptions are the result of extensive comparative genomics
among well studied papillomaviruses. For example, the E4
portion of the E1∧E4 mRNA is transcribed from the +1
reading frame of E2. Similarly, the E8 fragment of the
E8∧E2 protein is contained within the E1 +1 frame. Both
E1∧E4 and E8∧E2 utilize the same splice acceptor site lo-
cated within E2.
The E8∧E2 spliced transcript
Many papillomaviruses express a spliced transcript that en-
codes an E8∧E2 fusion protein (3,24). This protein consists
of a short peptide from anORF designated E8 (overlapping
the E1 ORF) fused to the C-terminal domain of E2. The re-
sulting proteins function as repressors of viral transcription
and replication (25). In the latest version of the annotation
pipeline, we have incorporated the algorithm described by
Puustusmaa and Abroi, to more accurately identify the E8
portion of the E8∧E2 coding regions (24).
The E6* transcript
The E6*I transcript is produced by internal splicing within
the E6 ORF. Within the so-called high-risk Alphapapillo-
maviruses the splice donor site is highly conserved. The
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Figure 1. Information Architecture of the PaVEWeb Resource. Architecture of the redesigned PaVE web interface, showing the three main ways to access
the data and tools using the concepts of ‘Search, ‘Analyse’ and ‘Explore’.
spliced transcript encodes a protein that contains the first
CxxC zinc-binding motif of E6 with the addition of a few
amino acids of variable non-conserved sequence encoded
by sequence following the acceptor site. To date, the E6*I
spliced mRNA has not been described in other viral species
or genera (reviewed in (7)). Currently, PaVE has annotated
only experimentally validated E6*I proteins (26). Efforts to
use sequence homology to aid in the prediction of addi-
tional E6*I proteins are underway.
The E5 proteins
The E5 proteins are short, hydrophobic, transmembrane
proteins (8). E5 genes are expressed from the region located
between the E2 and L2 ORFs, however sometimes more
than one hydrophobic E5-like protein can be encoded by
this region (27). Different E5 protein share little sequence
similarity. E5 proteins derived from Alphapapillomaviruses
have been named in PaVE as E5-alpha, E5-beta, E5-gamma
and E5-delta according to the scheme suggested by Bravo
and Alonso (27). Using a similar naming scheme, PaVE has
added E5-epsilon and E5-zeta.
The E10 proteins
In addition to the E5 proteins expressed from the region
located between the E2 and L2, a few viruses encode hy-
drophobic ‘E5 like’ proteins expressed from an ORF that
either overprints the E6 ORF, or is encoded in this region in
the absence of an E6 gene. These proteins have been named
either E5, or E8, which has led to confusion because of
the existence of the E8 exon (derived from the E1 ORF)
that generates the widely encoded E8∧E2 protein. In July
2016, key members of the papillomavirus community de-
cided to name hydrophobic ‘E5-like’ peptides encoded in
the 5′ early region, E10. These changes have been imple-
mented in the PaVE database, and an informational page
describing the E10 protein has been added. E10 proteins en-
coded by the bovineXipapillomaviruses were originally des-
ignated E8 (28), and are now renamed E10. SfPV1 contains
an ORF within E6 that is similar to the HPV and BPV1 E5
proteins and was previously designated E8 (29); it is also
renamed E10. Finally, members of Gammapapillomavirus
species 6 (HPV101, 103 and 108) lack a canonical E6 ORF,
but potentially encode a highly hydrophobic (E5-like) pro-
tein from an overlapping open reading frame, now also des-
ignated E10 (9).
Cis-elements
In addition to viral ORFs, the PaVE annotates cis-
regulatory elements, such as the Upstream Regulatory Re-
gion (URR) and DNA binding sites for the viral E2 regu-
latory protein [the relaxed ACCN(6)GGT consensus (3) is
used].
Circular genome browser
The PaVE locus viewer shows a linear representation of the
viral genome by default. However, PaVE also offers the abil-
ity to visualize the circular genome (Figure 2). This interac-
tive feature allows powerful navigation and analysis of in-
dividual viral features. The genes encoding for spliced tran-
scripts can be toggled on, or off.
Multiple sequence alignment and derivation of phylogenetic
trees
The analysis of a Multiple Sequence Alignment (MSA)
can be used to predict functional residues and conserved
motifs, aid in primer design and 3D structure prediction
(30). Sequence alignments can be used to infer evolution-
ary history and visualized in a phylogenetic tree. The PaVE
user interface can be used to select homologous protein se-
quences derived from viral types of interest (Figure 3). At
the click of a button, PaVE will calculate either a multiple
sequence alignment, or a neighbour-joining phylogenetic
tree. While several high quality multiple sequence aligners
are available, the COBALT aligner is used to construct the
alignments (31). COBALT leverages information present
in several databases (conserved domain database (32) and
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Figure 2. Circular genome browser. The PaVE locus view allows users to toggle between a linear and circular (shown here) representation of the viral
genome. Viral features annotated to HPV204 are shown and can be selected. The ‘selected feature details’ window displays additional information about
the ORF. The ‘coding region sequences’ window shows the nucleotide sequence for the selected ORF. Sequences can be further analysed using BLAST or
the PaVE structure viewer (1). Finally, the relative position of the selected feature is displayed.
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Figure 3. Integrated calculation of multiple sequence alignments and phylogenetic trees. An example of a typical analysis is shown. (A) Filters and pull-
down menus on the PaVE search page are used to select the protein sequences of interest. The applied filters are indicated in the orange box. Sequences can
be selected and used for the construction of a multiple sequence alignment or phylogenetic tree. (B) The first 80 amino-acids of a Cobalt based multiple
sequence alignment of the E2 proteins of nine highly divergent papillomaviruses is shown as displayed within Jalview. Residues are coloured according to
Clustal X. (C) The Neighbour-joining phylogenetic tree is displayed using JsPhyloSVG (39). If available, viral genera are included.
PROSITE protein-motif database (33) to define a collec-
tion of pairwise constraints. These constraints combined
with sequence similarity are incorporated into a progres-
sive multiple alignment. The MSA can be visualized using
Jalview (version 2.8, (34)), or can be downloaded for further
downstream analysis. For the phylogenetic tree construc-
tion, the neighbour-joining method (35,36) as implemented
in PAUP* (version 4.0b10, (37)) is used. The neighbour-
joining method is able to handle large datasets, making
it feasible to rapidly construct a single phylogenetic tree
of multiple homologous sequences present in the PaVE
database (37). The phylogenetic tree is displayed using Js-
PhyloSVG (38). While the PaVE generated phylogenetic
trees provide a representation of the evolutionary history of
the selected viruses, these trees are meant to be exploratory,
and therefore we recommend advanced tree building meth-
ods for detailed evolutionary analysis.
A static phylogenetic tree generated from multiple align-
ments using MAFFT (39) of all L1 nucleotide sequences
of all papillomavirus types currently in PaVE is also avail-
able. The tree was built using a maximum likelihood tree
in PhyML (40) implementing a gamma model allowing for
among-site rate variation and variable substitution rates
[GTR+I+G; model selected using jModeltest (41) and dis-
played using JsPhyloSVG (38)]. Within the graphical repre-
sentation, the names are linked back to the L1 sequence.
Enhanced structure viewer
The structure viewer allows the user to structurally align any
protein sequence from the PaVEdatabase with other related
structures in the PDB. To rectify alignment inaccuracies re-
sulting from inconsistent numbering of residues in PDB en-
tries (often arising from mutations in constructs used to
obtain structures or because only the structure of a single
domain had been solved), the PaVE includes a pipeline to
standardize the numbering. This has significantly improved
the user experience and allows the seamless browsing of ho-
mology structures without the need to verify the alignments
manually to adjust for these inconsistencies.
The table of available PV structures also includes links to
3D prints on the NIH 3D Print Exchange. NIH 3D Print
Exchange is a website that allows users to download, edit
and printmodels of biomolecules, such as proteins. 3Dprint
files have been generated for all protein structures in PaVE.
Image viewer
Distinct papillomavirus types have been isolated from di-
verse hosts. With few exceptions, these viral types are also
highly tropic to certain tissues in the host. Papillomavirus
infections can result in a wide range of clinical outcomes;
in many cases, infections are asymptomatic, while others re-
sult in flat macules or papular warts, verrucas, and condylo-
mas (42). PaVEnow incorporates an extensive image library
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Figure 4. PaVE image database. PaVE has collected images related to papillomavirus infections. These can be browsed using the PaVE Image Viewer. (A)
A screenshot of thumbnails in a portion of the image gallery. (B) Oral papillomatous lesions in a coyote. Courtesy of Kevin Keel, UC Davis School of
Veterinary Medicine. (C) H&E stain of a canine inverted papilloma. Courtesy of Patricia Pesavento, UC Davis School of Veterinary Medicine.
containing gross clinical and histopathological images from
a variety of lesions (Figure 4). If the specific causative viral
type was identified, the lesions can be searched and sorted
by associated virus.
Depending largely on community contributions, we wel-
come additionally contributions to enrich this repository.
Contributors can reach us via the PaVE contact page.
Contributors and users should carefully review the images
sources to determine whether copyright or permission for
further use is warranted. We ask that images not be altered,
and that credit be given to both original authors and to the
PaVE website.
Taxonomic classification of papillomavirus isolates; the L1
typing tool
Nucleotide identity across the L1 ORF is the basis for the
taxonomy of the family Papillomaviridae. If a novel isolate
shares less than 60% sequence identity with a known type
it is considered to belong to a new genus, 70% identity de-
marcates different species within a genus. To be considered
a new type, the isolate cannot share>90% sequence identity
to a known virus (14). This approach requires the calcula-
tion of hundreds of pairwise sequence comparisons. Fur-
thermore, the use of different alignment algorithms and/or
parameters could affect the conclusion of this analysis. To
streamline this process, an L1 specific typing tool has been
developed and incorporated in the PaVE (Figure 5). As
implemented, the typing process consists of several subse-
quent steps. Initially the query sequence is aligned to all
L1 sequences in the PaVE database using the profile align-
ment functions of MAFFT (39). Next, a distance matrix
is constructed based on pairwise alignments (Needleman–
Wunsch algorithm; (43)). Finally, a neighbour-joining phy-
logenetic tree is built using PAUP* (Phylogenetic Analysis
Using Parsimony*; (44)). Both the phylogenetic tree and
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Figure 5. L1 based taxonomic classification. The PaVE taxonomy tool is designed to aid researchers in preliminary classification of novel papillomaviruses.
(A) The tool accepts the L1 nucleotide sequence in FastA format. The sequence can be uploaded, or pasted into the search box. (B) Results are summarized,
andmore detailed information is provided, in multiple formats. (C) The phylogenetic position of the submitted L1 sequence is displayed. For representation
purposes, the tree was cropped from the full tree. Dotted lines indicate that the tree continues along the indicated branch.
the nucleotide identity cut-off values are used to determine
whether the query sequence should be considered a new
type. The reliability of clustering in the neighbour-joining
tree is assessed using 100 bootstrap replicates, using a 70%
cut-off value.
Importantly, while the typing tool informs users whether
their new isolate is different from other named viruses in
PaVE, it cannot determine whether the additional criteria
for a new type (cloned genome, submitted to the HPV Ref-
erence Center) are met. The papillomavirus study group of
the International Committee on the Taxonomy of Viruses
(ICTV)) is the only recognized authority for nomenclature
of new papillomaviruses. The L1 typing tool is intended
only to aid the researcher with the initial steps in submit-
ting a putative novel viral type.
User support
PaVE has a Support page that contains Fre-
quently Asked Questions and a User Manual. Sub-
mission of the Request Support form (pavesup-
port@collabmail.niaid.nih.gov) yields quick responses
by the NIAID PaVE group. Information about PaVE
is disseminated through the PaVE Facebook site
https://www.facebook.com/PapillomavirusEpisteme and
by outreach efforts at major HPV conferences.
Review chapters
The PaVE database is accompanied by a special issue of the
Elsevier journal ‘Virology’, entitled Functional Genomics
of Papillomaviruses (45). The goal of these accompanying
papers was to provide an unbiased, encyclopedic overview
of different aspects of papillomavirus genomics, proteomics,
and related disease. Each article in the special issue is open
access and indexed in PubMed. Full text articles are avail-
able directly through the PaVEwebsite, or from the Elsevier
website. The information embedded within these chapters
serves as an important knowledge resource for the scientific
community.
CONCLUSIONS
The goal of the PaVE is to assist the study of papillo-
mavirus biology and to aid in the development of thera-
peutics and diagnostics. This paper describes updates and
improvements to the PaVE database, which was first de-
scribed in 2013 (1). Since the previous description, a steadily
increasing number of papillomaviruses has been described
using high-throughput, metagenomic approaches. A recent
metagenomic study describes 226 putative novel HPV types
amplified from different human lesions (46). Furthermore,
there is an increasing interest in animal virology and it is
expected that the virome of non-human animals will ex-
tend the papillomavirus sequence universe with thousands
of novel types. PaVE will be able to assist in the herculean
task of annotating, cataloguing and classifying these vi-
ral genomes. Moreover, the ever-expanding array of bioin-
formatics tools integrated within the PaVE database ele-
vates PaVE to a papillomavirus knowledgebase rather than
a compilation of genomic data.
In conclusion, PaVE provides the papillomavirus
community with access to uniformly curated Reference
genomes, thereby ensuring that scientists across several dis-
ciplines study the same prototype genome, thus improving
communication, data reporting and reproducibility.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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